Surgeons were able to identify and remove a greater number of cancerous nodules from lung cancer patients when combining intraoperative molecular imaging (IMI) -- through the use of a contrast agent that makes tumor cells glow during surgery -- with preoperative positron emission tomography (PET) scans. The study from the Abramson Cancer Center at the University of Pennsylvania (ACC) is the first to show how effective the combination of IMI with the tumor-glowing agent can be when combined with traditional PET imaging. Researchers published their findings today in Annals of Surgery.
